Iovance Biotherapeutics Inc (IOVA)
11.44
-0.02
(-0.17%)
USD |
NASDAQ |
Nov 05, 11:18
Iovance Biotherapeutics Profit Margin (Quarterly): -312.2% for June 30, 2024
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | -312.2% |
| March 31, 2024 | -15.80K% |
| December 31, 2023 | -24.15K% |
| Date | Value |
|---|---|
| September 30, 2023 | -24.26K% |
| June 30, 2023 | -44.76K% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-44.76K%
Minimum
Jun 2023
-312.2%
Maximum
Jun 2024
-21.85K%
Average
-24.15K%
Median
Dec 2023
Profit Margin (Quarterly) Benchmarks
| Perspective Therapeutics Inc | -- |
| Electromed Inc | 12.32% |
| Xtant Medical Holdings Inc | -12.89% |
| Myomo Inc | -14.91% |
| Catheter Precision Inc | -4.54K% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -66.99% |
| Return on Assets | -52.11% |
| Return on Invested Capital | -66.89% |
| Gross Profit Margin (Quarterly) | -0.84% |
| Operating Margin (Quarterly) | -327.6% |
| Return on Net Operating Assets | -96.36% |